October 3 - 4, 2016
Hilton San Diego Mission Valley
San Diego, CA
Event website: Click here (http://www.biomarkersusa-congress.com)
Attended by over 200 participants from the pharmaceutical industry, the congress offers a balance of scientific presentations and networking opportunities. In line with the current industry trends, day one of the congress focuses on the identification of safety biomarkers, the translation of biomarkers from the discovery to the early development stages as well as personalized health care. Expert case studies will also cover insights into novel biomarker discoveries and development in different therapeutic areas such as CNS diseases, neuroscience and infectious diseases.
The companion diagnostics & personalized medicine stream features the latest updates in companion diagnostics developments, regulatory updates and the future of targeted therapy, precision medicine and patient self-monitoring in health care.
On day two of the congress, the innovation stream features insightful case study presentations on novel biomarker technologies such as informatics and data management, imaging technologies and cytometry. The emphasis is also on using the most appropriate assays and how to develop these into validated analytical methods suitable for clinical practice.